These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 1421706)
1. [Growth factors and intestinal cancers]. Pommier G Bull Cancer; 1992; 79(5):427-49. PubMed ID: 1421706 [TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta in intestinal epithelial differentiation and neoplasia (review). Lamprecht SA; Schwartz B; Glicksman A Anticancer Res; 1989; 9(6):1877-81. PubMed ID: 2697192 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture. Liu C; Tsao MS; Grisham JW Cancer Res; 1988 Feb; 48(4):850-5. PubMed ID: 3276400 [TBL] [Abstract][Full Text] [Related]
5. Colon absorptive epithelial cells lose proliferative response to TGF alpha as they differentiate. Huang F; Sauma S; Yan Z; Friedman E Exp Cell Res; 1995 Jul; 219(1):8-14. PubMed ID: 7628553 [TBL] [Abstract][Full Text] [Related]
6. Mammary epithelial cells treated concurrently with TGF-alpha and TGF-beta exhibit enhanced proliferation and death. Casey TM; Mulvey TM; Patnode TA; Dean A; Zakrzewska E; Plaut K Exp Biol Med (Maywood); 2007 Sep; 232(8):1027-40. PubMed ID: 17720949 [TBL] [Abstract][Full Text] [Related]
7. The role for transforming growth factor-beta (TGF-beta) in human cancer. Gold LI Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929 [TBL] [Abstract][Full Text] [Related]
8. Roles of growth factors and of tumor necrosis factor-alpha on liver cell proliferation induced in rats by lead nitrate. Shinozuka H; Kubo Y; Katyal SL; Coni P; Ledda-Columbano GM; Columbano A; Nakamura T Lab Invest; 1994 Jul; 71(1):35-41. PubMed ID: 8041116 [TBL] [Abstract][Full Text] [Related]
9. Regulation of prostatic growth and function by peptide growth factors. Culig Z; Hobisch A; Cronauer MV; Radmayr C; Hittmair A; Zhang J; Thurnher M; Bartsch G; Klocker H Prostate; 1996 Jun; 28(6):392-405. PubMed ID: 8650077 [TBL] [Abstract][Full Text] [Related]
10. Biogenic amines as regulators of the proliferative activity of normal and neoplastic intestinal epithelial cells (review). Tutton PJ; Barkla DH Anticancer Res; 1987; 7(1):1-12. PubMed ID: 3032070 [TBL] [Abstract][Full Text] [Related]
11. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III. Deng X; Bellis S; Yan Z; Friedman E Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. Labbé E; Lock L; Letamendia A; Gorska AE; Gryfe R; Gallinger S; Moses HL; Attisano L Cancer Res; 2007 Jan; 67(1):75-84. PubMed ID: 17210685 [TBL] [Abstract][Full Text] [Related]
13. Transformation-related growth factors and their receptors. Bregman MD; Sipes NJ Int J Cell Cloning; 1986 Jul; 4(4):224-36. PubMed ID: 3018097 [TBL] [Abstract][Full Text] [Related]
15. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells. Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393 [TBL] [Abstract][Full Text] [Related]
16. The nucleocytoplasmic shuttling of E2F4 is involved in the regulation of human intestinal epithelial cell proliferation and differentiation. Deschênes C; Alvarez L; Lizotte ME; Vézina A; Rivard N J Cell Physiol; 2004 May; 199(2):262-73. PubMed ID: 15040009 [TBL] [Abstract][Full Text] [Related]
17. The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach. Favoni RE; de Cupis A Pharmacol Rev; 2000 Jun; 52(2):179-206. PubMed ID: 10835099 [TBL] [Abstract][Full Text] [Related]
18. Transformation of intestinal epithelial cells by chronic TGF-beta1 treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2. Sheng H; Shao J; O'Mahony CA; Lamps L; Albo D; Isakson PC; Berger DH; DuBois RN; Beauchamp RD Oncogene; 1999 Jan; 18(4):855-67. PubMed ID: 10023661 [TBL] [Abstract][Full Text] [Related]
19. The effect of transforming growth factor beta on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling. Leu FP; Nandi M; Niu C Mol Cancer Res; 2008 Jun; 6(6):1029-42. PubMed ID: 18567806 [TBL] [Abstract][Full Text] [Related]
20. [Different regulation systems of cell cycle events (dysregulation of these events in the tumoral cell)]. Colomb E; Martin PM Bull Cancer; 1991 Jan; 78(1):1-21. PubMed ID: 2021683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]